Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas.
Fariba GhassemiShahab SheibaniMojtaba ArjmandHosein PoorbaygiEmad KouhestaniSiamafk SabourFarhad SamieiAkbar Beiki-ArdakaniMahmood JabarvandAli Sadeghi TariPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
The treatment with our 125I plaques is as effective as 106Ru plaques in controlling choroidal melanoma tumor and preserving the vision during the two and half year of follow-up. The complication rates are alike. It means that the effectiveness of 125I is not only comparable to 106Ru but also superior when the outcome of the interest is the thickness of the tumors.